Cargando…
The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain
OBJECTIVE: To evaluate the relationship between opioid use and specific personality traits among individuals with chronic pain stratified by morphine equivalent doses (MEQ). DESIGN: Observational cohort study. Setting. Chronic pain outpatient clinic in Canada (2017–2019). Patients. Participants were...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261182/ https://www.ncbi.nlm.nih.gov/pubmed/34257765 http://dx.doi.org/10.1155/2021/9946067 |
_version_ | 1783718961610752000 |
---|---|
author | McIntyre, Amanda Mehta, Swati Vanderlaan, Danielle Sequeira, Keith Loh, Eldon Teasell, Robert |
author_facet | McIntyre, Amanda Mehta, Swati Vanderlaan, Danielle Sequeira, Keith Loh, Eldon Teasell, Robert |
author_sort | McIntyre, Amanda |
collection | PubMed |
description | OBJECTIVE: To evaluate the relationship between opioid use and specific personality traits among individuals with chronic pain stratified by morphine equivalent doses (MEQ). DESIGN: Observational cohort study. Setting. Chronic pain outpatient clinic in Canada (2017–2019). Patients. Participants were included if they (1) were at least 18 years old, (2) had been diagnosed with chronic pain (pain >3 months), and (3) were able to read and write in English. Interventions. None. Main Outcome Measures. Completion of the following outcome measures: Acceptance and Action Questionnaire, Anxiety Sensitivity Index, Brief-Coping with Problems Experience 28-item, Brief Pain Inventory Short Form, CAGE-AID substance misuse screening tool, EuroQol-5D, Generalized Anxiety Disorder 7-item, and Patient Health Questionnaire 9-item. One-way analysis of variance compared outcomes between MEQ groups. RESULTS: 215 individuals (64.2% female) were included with a mean age of 52.7 ± 11.7 years and time since pain onset of 14.1 ± 10.2 years (range 1–45). There were no significant differences between MEQ groups with respect to sociodemographic and clinical health variables except for gender and employment status and time since pain onset. After controlling for gender, time since pain onset, and average pain severity, patients with MEQ 90+ mg had significantly higher scores for experiential avoidance and anxiety sensitivity in addition to increased pain interference, greater depressive and anxiety symptoms, more dysfunctional coping, and poorer QoL than those with MEQ 1–89 mg or MEQ 0 mg. CONCLUSIONS: Compared to individuals using no or lower-dose opioids to treat chronic pain, those using high-dose opioids had higher scores on two maladaptive personality traits (i.e., anxiety sensitivity and experiential avoidance) which was associated with poorer mood, greater pain interference, lower quality of life, and dysfunctional coping. These maladaptive personality traits may help to explain how individuals with chronic pain utilize higher doses of opioid analgesics. |
format | Online Article Text |
id | pubmed-8261182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-82611822021-07-12 The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain McIntyre, Amanda Mehta, Swati Vanderlaan, Danielle Sequeira, Keith Loh, Eldon Teasell, Robert Pain Res Manag Research Article OBJECTIVE: To evaluate the relationship between opioid use and specific personality traits among individuals with chronic pain stratified by morphine equivalent doses (MEQ). DESIGN: Observational cohort study. Setting. Chronic pain outpatient clinic in Canada (2017–2019). Patients. Participants were included if they (1) were at least 18 years old, (2) had been diagnosed with chronic pain (pain >3 months), and (3) were able to read and write in English. Interventions. None. Main Outcome Measures. Completion of the following outcome measures: Acceptance and Action Questionnaire, Anxiety Sensitivity Index, Brief-Coping with Problems Experience 28-item, Brief Pain Inventory Short Form, CAGE-AID substance misuse screening tool, EuroQol-5D, Generalized Anxiety Disorder 7-item, and Patient Health Questionnaire 9-item. One-way analysis of variance compared outcomes between MEQ groups. RESULTS: 215 individuals (64.2% female) were included with a mean age of 52.7 ± 11.7 years and time since pain onset of 14.1 ± 10.2 years (range 1–45). There were no significant differences between MEQ groups with respect to sociodemographic and clinical health variables except for gender and employment status and time since pain onset. After controlling for gender, time since pain onset, and average pain severity, patients with MEQ 90+ mg had significantly higher scores for experiential avoidance and anxiety sensitivity in addition to increased pain interference, greater depressive and anxiety symptoms, more dysfunctional coping, and poorer QoL than those with MEQ 1–89 mg or MEQ 0 mg. CONCLUSIONS: Compared to individuals using no or lower-dose opioids to treat chronic pain, those using high-dose opioids had higher scores on two maladaptive personality traits (i.e., anxiety sensitivity and experiential avoidance) which was associated with poorer mood, greater pain interference, lower quality of life, and dysfunctional coping. These maladaptive personality traits may help to explain how individuals with chronic pain utilize higher doses of opioid analgesics. Hindawi 2021-06-28 /pmc/articles/PMC8261182/ /pubmed/34257765 http://dx.doi.org/10.1155/2021/9946067 Text en Copyright © 2021 Amanda McIntyre et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article McIntyre, Amanda Mehta, Swati Vanderlaan, Danielle Sequeira, Keith Loh, Eldon Teasell, Robert The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain |
title | The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain |
title_full | The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain |
title_fullStr | The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain |
title_full_unstemmed | The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain |
title_short | The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain |
title_sort | relationship between higher chronic opioid therapy dose and specific personality traits in individuals with chronic pain |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261182/ https://www.ncbi.nlm.nih.gov/pubmed/34257765 http://dx.doi.org/10.1155/2021/9946067 |
work_keys_str_mv | AT mcintyreamanda therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT mehtaswati therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT vanderlaandanielle therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT sequeirakeith therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT loheldon therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT teasellrobert therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT mcintyreamanda relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT mehtaswati relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT vanderlaandanielle relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT sequeirakeith relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT loheldon relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain AT teasellrobert relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain |